Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tziakas DN et al. – The present study showed, that use of statins is associated with a reduction in CEM, an emerging marker of clinical instability and plaque vulnerability in CAD patients. The pleiotropic effects of statins at the cell membrane level represent a promising novel direction for research in CAD.

Exclusive Author Commentary
Dimitrios N. Tziakas, 10/21/09

We believe that as cholesterol content of erythrocyte membranes is identified as a novel marker for clinical instability in coronary artery disease new diagnostic and therapeutic approaches are emerging. Statins, whose prognostic benefit lies well beyond their lipid lowering effect seem a potent canditate that can modulate cholesterol metabolism at the cell membrane level

Related Articles

Screening for Subclinical Coronary Artery Disease Measuring Carotid Intima Media Thickness
The American Journal of Cardiology, 11/10/09    Relevance Score: 83%

Prognostic significance of left ventricular mass by magnetic resonance imaging study in patients with known or suspected coronary artery disease
Journal of Hypertension, 10/28/09    Relevance Score: 83%

Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systematic review
Journal of Nuclear Cardiology, 10/28/09    Relevance Score: 83%

Coronary Artery Disease in Patients With Peripheral Artery Disease
Heart & Lung; The Journal of Acute and Critical Care, 10/27/09    Relevance Score: 83%

Coronary artery disease threatens millions, but early diagnosis, treatment can reduce risk
Internet Source, 10/06/09    Relevance Score: 83%

Today in Atherosclerosis/Lipids...keeping you current

Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/10/09

Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy
Current Medical Research and Opinion, 12/10/09

Low-density lipoprotein and apolipoprotein B: Clinical use in patients with coronary heart disease
Current Cardiology Reports, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address